Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05674370 · ClinicalTrials.gov registry record · NA
A Study of the GRIP Influenza and SARS-CoV-2 POC Assays
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05674370: Completed NA study, sponsored by Mayo Clinic.
NCT05674370 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05674370, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if the use of a new device can accurately detect a virus infection.
Primary Outcome
Percent of nasal swabs to report positive results for respiratory virus for both the GRIP device and NAAT routine clinical testing
Interventions
- DEVICE GRIP Electronic Diagnostic Chip
- DIAGNOSTIC_TEST Laboratory-based nucleic acid amplification tests (NAATs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT05674370 record still lists
NCT05674370 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which GRIP Electronic Diagnostic Chip is the first listed.
NCT05674370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05674370 about?
NCT05674370 is a clinical study titled "A Study of the GRIP Influenza and SARS-CoV-2 POC Assays". The purpose of this research is to determine if the use of a new device can accurately detect a virus infection.
What is the current status of trial NCT05674370?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2023-02-01. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT05674370?
The interventions under investigation include: GRIP Electronic Diagnostic Chip (DEVICE), Laboratory-based nucleic acid amplification tests (NAATs) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05674370?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05674370's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI